Rowan T Chlebowski, M.D., Ph.D.

Edit your Faculty Profile
Work Titles
The Lundquist Institute for Biomedical Innovation Chief, Professor In-Residence, MEDICAL ONCOLOGY/HEMATOLOGY
Education:
Degrees:
M.D.
Ph.D.

Contact Information:

Work Email Address:

rchlebow@whi.org

Work Email Address:

rchlebowski@gmail.com


Fax Number:

(310) 320-2564

Work Phone Number:

(310) 222-2217

Mailing Address:

1124 West Carson Street J-3
mailbox 453
Torrance, CA 90502

mail box 453


Work Address:

Harbor-UCLA Medical Center, Bldg J-3 1000 West Carson Street
Torrance, CA 90509
CA


Publications:

A selected list of publications:

Chlebowski Rowan T   Changing concepts of hormone receptor-positive advanced breast cancer therapy Clinical breast cancer, 2013; 13(3): 159-66.
Chlebowski Rowan T, Cirillo Dominic J, Eaton Charles B, Stefanick Marcia L, Pettinger Mary, Carbone Laura D, Johnson Karen C, Simon Michael S, Woods Nancy F, Wactawski-Wende Jean   Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial Menopause (New York, N.Y.), 2013; 20(6): 600-608.
Chlebowski Rowan T, Manson JoAnn E, Anderson Garnet L, Cauley Jane A, Aragaki Aaron K, Stefanick Marcia L, Lane Dorothy S, Johnson Karen C, Wactawski-Wende Jean, Chen Chu, Qi Lihong, Yasmeen Shagufta, Newcomb Polly A, Prentice Ross L   Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study Journal of the National Cancer Institute, 2013; 105(8): 526-35.
Salmoirago-Blotcher Elena, Fitchett George, Hovey Kathleen M, Schnall Eliezer, Thomson Cynthia, Andrews Christopher A, Crawford Sybil, O'Sullivan Mary Jo, Post Stephen, Chlebowski Rowan T, Ockene Judith   Frequency of private spiritual activity and cardiovascular risk in postmenopausal women: the Women's Health Initiative Annals of epidemiology, 2013; 23(5): 239-45.
Passarelli Michael N, Newcomb Polly A, Lacroix Andrea Z, Lane Dorothy S, Ho Gloria Y F, Chlebowski Rowan T   Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2013; 105(8): .
Livaudais Jennifer C, Lacroix Andrea, Chlebowski Rowan T, Li Christopher I, Habel Laurel A, Simon Michael S, Thompson Beti, Erwin Deborah O, Hubbell F Allan, Coronado Gloria D   Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013; 22(3): 365-73.
Chlebowski Rowan T   Vitamin d and breast cancer incidence and outcome Anti-cancer agents in medicinal chemistry, 2013; 13(1): 98-106.
Kwan Karen, Chlebowski Rowan T, McTiernan Anne, Rodabough Rebecca J, La Monte Michael J, Martin Lisa W, Bell Christina, Lane Dorothy S, Kaplan Robert C, Irwin Melinda L   Walking speed, physical activity, and breast cancer in postmenopausal women European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2013; 20(6): .
Ho Gloria Y F, Wang Tao, Gunter Marc J, Strickler Howard D, Cushman Mary, Kaplan Robert C, Wassertheil-Smoller Sylvia, Xue Xiaonan, Rajpathak Swapnil N, Chlebowski Rowan T, Vitolins Mara Z, Scherer Philipp E, Rohan Thomas E   Adipokines linking obesity with colorectal cancer risk in postmenopausal women Cancer research, 2012; 72(12): 3029-37.
Bukowski Radek, Chlebowski Rowan T, Thune Inger, Furberg Anne-Sofie, Hankins Gary D V, Malone Fergal D, D'Alton Mary E   Birth weight, breast cancer and the potential mediating hormonal environment PloS one, 2012; 7(7): e40199.
Chlebowski Rowan T, Col Nananda   Bisphosphonates and breast cancer prevention Anti-cancer agents in medicinal chemistry, 2012; 12(2): 144-50.
Crandall Carolyn J, Aragaki Aaron K, Cauley Jane A, McTiernan Anne, Manson Joann E, Anderson Garnet L, Wactawski-Wende Jean, Chlebowski Rowan T   Breast tenderness after initiation of conjugated equine estrogens and mammographic density change Breast cancer research and treatment, 2012; 131(3): 969-79.
Crandall Carolyn J, Aragaki Aaron K, Cauley Jane A, McTiernan Anne, Manson Joann E, Anderson Garnet, Chlebowski Rowan T   Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials Breast cancer research and treatment, 2012; 132(1): 275-85.
Chlebowski Rowan T, Pettinger Mary, Kooperberg Charles   Caution in reinterpreting the Women's Health Initiative (WHI) Calcium and Vitamin D Trial breast cancer results The American journal of clinical nutrition, 2012; 95(1): 258-9; author reply 259.
Chlebowski Rowan T, Anderson Garnet L   Changing concepts: Menopausal hormone therapy and breast cancer Journal of the National Cancer Institute, 2012; 104(7): 517-27.
Anderson Garnet L, Chlebowski Rowan T, Aragaki Aaron K, Kuller Lewis H, Manson JoAnn E, Gass Margery, Bluhm Elizabeth, Connelly Stephanie, Hubbell F Allan, Lane Dorothy, Martin Lisa, Ockene Judith, Rohan Thomas, Schenken Robert, Wactawski-Wende Jean   Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial The lancet oncology, 2012; 13(5): 476-86.
Chlebowski Rowan T, McTiernan Anne, Wactawski-Wende Jean, Manson JoAnn E, Aragaki Aaron K, Rohan Thomas, Ipp Eli, Kaklamani Virginia G, Vitolins Mara, Wallace Robert, Gunter Marc, Phillips Lawrence S, Strickler Howard, Margolis Karen, Euhus David M   Diabetes, metformin, and breast cancer in postmenopausal women Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012; 30(23): 2844-52.
Simon Michael S, Chlebowski Rowan T, Wactawski-Wende Jean, Johnson Karen C, Muskovitz Andrew, Kato Ikuko, Young Alicia, Hubbell F Allan, Prentice Ross L   Estrogen plus progestin and colorectal cancer incidence and mortality Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012; 30(32): 3983-90.
Huang Ying, Ballinger Dennis G, Dai James Y, Peters Ulrike, Hinds David A, Cox David R, Beilharz Erica, Chlebowski Rowan T, Rossouw Jacques E, McTiernan Anne, Rohan Thomas, Prentice Ross L   Genetic variants in the MRPS30 region and postmenopausal breast cancer risk Genome medicine, 2012; 4(3): 19.
Tippin Brigette L, Levine A Joan, Materi Alicia M, Song Wen-Liang, Keku Temitope O, Goodman Julie E, Sansbury Leah B, Das Sudipto, Dai Aihua, Kwong Alan M, Lin Amy M, Lin John M, Park Jae Man, Patterson Ruth E, Chlebowski Rowan T, Garavito R Michael, Inoue Tsuyoshi, Cho Wonhwa, Lawson John A, Kapoor Shiv, Kolonel Laurence N, Le Marchand Loïc, Haile Robert W, Sandler Robert S, Lin Henry J   Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer Prostaglandins & other lipid mediators, 2012; 97(1-2): 22-8.
Mackey Rachel H, Fanelli Theresa J, Modugno Francesmary, Cauley Jane A, McTigue Kathleen M, Brooks Maria Mori, Chlebowski Rowan T, Manson JoAnn E, Klug Thomas L, Kip Kevin E, Curb J David, Kuller Lewis H   Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012; 21(11): 2022-32.
Col Nananda F, Ochs Leslie, Springmann Vicky, Aragaki Aaron K, Chlebowski Rowan T   Metformin and breast cancer risk: a meta-analysis and critical literature review Breast cancer research and treatment, 2012; 135(3): 639-46.
Chlebowski Rowan T   Obesity and breast cancer outcome: adding to the evidence Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012; 30(2): 126-8.
Wolpin Brian M, Ng Kimmie, Bao Ying, Kraft Peter, Stampfer Meir J, Michaud Dominique S, Ma Jing, Buring Julie E, Sesso Howard D, Lee I-Min, Rifai Nader, Cochrane Barbara B, Wactawski-Wende Jean, Chlebowski Rowan T, Willett Walter C, Manson JoAnn E, Giovannucci Edward L, Fuchs Charles S   Plasma 25-hydroxyvitamin D and risk of pancreatic cancer Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012; 21(1): 82-91.
Chlebowski Rowan T, Col Nananda   Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors The breast journal, 2012; 18(4): 299-302.
Hvidtfeldt Ulla A, Gunter Marc J, Lange Theis, Chlebowski Rowan T, Lane Dorothy, Farhat Ghada N, Freiberg Matthew S, Keiding Niels, Lee Jennifer S, Prentice Ross, Tjønneland Anne, Vitolins Mara Z, Wassertheil-Smoller Silvia, Strickler Howard D, Rod Naja H   Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012; 21(7): 1203-12.
Kuiper Josephina G, Phipps Amanda I, Neuhouser Marian L, Chlebowski Rowan T, Thomson Cynthia A, Irwin Melinda L, Lane Dorothy S, Wactawski-Wende Jean, Hou Lifang, Jackson Rebecca D, Kampman Ellen, Newcomb Polly A   Recreational physical activity, body mass index, and survival in women with colorectal cancer Cancer causes & control : CCC, 2012; 23(12): 1939-48.
Lin Jennifer H, Gunter Marc J, Manson JoAnn E, Rexrode Kathryn M, Cook Nancy R, Kraft Peter, Cochrane Barbara B, Chlebowski Rowan T, Ho Gloria Y F, Zhang Shumin M   The aromatase gene (CYP19A1) variants and circulating hepatocyte growth factor in postmenopausal women PloS one, 2012; 7(7): e42079.
Bertone-Johnson Elizabeth R, McTiernan Anne, Thomson Cynthia A, Wactawski-Wende Jean, Aragaki Aaron K, Rohan Thomas E, Vitolins Mara Z, Tamimi Rulla M, Johnson Karen C, Lane Dorothy, Rexrode Kathryn M, Peck Jennifer D, Chlebowski Rowan T, Sarto Gloria, Manson Joann E   Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012; 21(3): 462-73.
Chlebowski Rowan T, Johnson Karen C, Lane Dorothy, Pettinger Mary, Kooperberg Charles L, Wactawski-Wende Jean, Rohan Tom, O'Sullivan Mary Jo, Yasmeen Shagufta, Hiatt Robert A, Shikany James M, Vitolins Mara, Khandekar Janu, Hubbell F Allan   25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women Maturitas, 2011; 68(1): 73-8.
Chlebowski Rowan T, Col Nananda   Bisphosphonates and breast cancer incidence and recurrence Breast disease, 2011; 33(2): 93-101.
Phipps Amanda I, Chlebowski Rowan T, Prentice Ross, McTiernan Anne, Stefanick Marcia L, Wactawski-Wende Jean, Kuller Lewis H, Adams-Campbell Lucile L, Lane Dorothy, Vitolins Mara, Kabat Geoffrey C, Rohan Thomas E, Li Christopher I   Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011; 20(3): 454-63.
Yasmeen Shagufta, Xing Guibo, Morris Cyllene, Chlebowski Rowan T, Romano Patrick S   Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis Cancer, 2011; 117(14): 3252-61.
Shikany James M, Redden David T, Neuhouser Marian L, Chlebowski Rowan T, Rohan Thomas E, Simon Michael S, Liu Simin, Lane Dorothy S, Tinker Lesley   Dietary glycemic load, glycemic index, and carbohydrate and risk of breast cancer in the Women's Health Initiative Nutrition and cancer, 2011; 63(6): 899-907.
Chlebowski Rowan T   Emerging role for bisphosphonates in cancer management Breast disease, 2011; 33(2): 55-7.
Lin Jennifer H, Manson JoAnn E, Kraft Peter, Cochrane Barbara B, Gunter Marc J, Chlebowski Rowan T, Zhang Shumin M   Estrogen and progesterone-related gene variants and colorectal cancer risk in women BMC medical genetics, 2011; 12(6): 78.
Goss Paul E, Ingle James N, Alés-Martínez José E, Cheung Angela M, Chlebowski Rowan T, Wactawski-Wende Jean, McTiernan Anne, Robbins John, Johnson Karen C, Martin Lisa W, Winquist Eric, Sarto Gloria E, Garber Judy E, Fabian Carol J, Pujol Pascal, Maunsell Elizabeth, Farmer Patricia, Gelmon Karen A, Tu Dongsheng, Richardson Harriet, Richardson Harriet   Exemestane for breast-cancer prevention in postmenopausal women The New England journal of medicine, 2011; 364(25): 2381-91.
Huang Ying, Ballinger Dennis G, Dai James Y, Peters Ulrike, Hinds David A, Cox David R, Beilharz Erica, Chlebowski Rowan T, Rossouw Jacques E, McTiernan Anne, Rohan Thomas, Prentice Ross L   Genetic variants in the MRPS30 region and postmenopausal breast cancer risk Genome medicine, 2011; 3(6): 42.
LaCroix Andrea Z, Chlebowski Rowan T, Manson JoAnn E, Aragaki Aaron K, Johnson Karen C, Martin Lisa, Margolis Karen L, Stefanick Marcia L, Brzyski Robert, Curb J David, Howard Barbara V, Lewis Cora E, Wactawski-Wende Jean, Wactawski-Wende Jean   Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial JAMA : the journal of the American Medical Association, 2011; 305(13): 1305-14.
Bodelon Clara, Anderson Garnet L, Rossing Mary Anne, Chlebowski Rowan T, Ochs-Balcom Heather M, Vaughan Thomas L   Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women Cancer prevention research (Philadelphia, Pa.), 2011; 4(6): 840-50.
Kerwin Diana R, Gaussoin Sarah A, Chlebowski Rowan T, Kuller Lewis H, Vitolins Mara, Coker Laura H, Kotchen Jane M, Nicklas Barbara J, Wassertheil-Smoller Sylvia, Hoffmann Raymond G, Espeland Mark A, Espeland Mark A   Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the Women's Health Initiative Memory Study Journal of the American Geriatrics Society, 2011; 59(1): 107-12.
Tang Jean Y, Spaunhurst Katrina M, Chlebowski Rowan T, Wactawski-Wende Jean, Keiser Elizabeth, Thomas Fridtjof, Anderson Matthew L, Zeitouni Nathalie C, Larson Joseph C, Stefanick Marcia L   Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials Journal of the National Cancer Institute, 2011; 103(19): 1469-75.
Simon Michael S, Thomson Cynthia A, Pettijohn Erin, Kato Ikuko, Rodabough Rebecca J, Lane Dorothy, Hubbell F Allan, O'Sullivan Mary Jo, Adams-Campbell Lucille, Mouton Charles P, Abrams Judith, Chlebowski Rowan T   Racial differences in colorectal cancer incidence and mortality in the Women's Health Initiative Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011; 20(7): 1368-78.
Michael Yvonne L, Carlson Nichole E, Bowen Deborah J, Ritenbaugh Cheryl, Chlebowski Rowan T, Weihs Karen L, Ockene Judith K   Re: "Invited commentary: personality as a causal factor in cancer risk and mortality--time to retire a hypothesis?" American journal of epidemiology, 2011; 173(6): 716; author reply 716-7.
Kabat Geoffrey C, Kim Mimi Y, Woods Nancy F, Habel Laurel A, Messina Catherine R, Wactawski-Wende Jean, Stefanick Marcia L, Chlebowski Rowan T, Wassertheil-Smoller Sylvia, Rohan Thomas E   Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women Cancer causes & control : CCC, 2011; 22(10): 1415-24.
Phipps Amanda I, Chlebowski Rowan T, Prentice Ross, McTiernan Anne, Wactawski-Wende Jean, Kuller Lewis H, Adams-Campbell Lucile L, Lane Dorothy, Stefanick Marcia L, Vitolins Mara, Kabat Geoffrey C, Rohan Thomas E, Li Christopher I   Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer Journal of the National Cancer Institute, 2011; 103(6): 470-7.
Farhat Ghada N, Cummings Steven R, Chlebowski Rowan T, Parimi Neeta, Cauley Jane A, Rohan Thomas E, Huang Alison J, Vitolins Mara, Hubbell F Allan, Manson Joann E, Cochrane Barbara B, Lane Dorothy S, Lee Jennifer S   Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers Journal of the National Cancer Institute, 2011; 103(7): 562-70.
Brunner Robert L, Wactawski-Wende Jean, Caan Bette J, Cochrane Barbara B, Chlebowski Rowan T, Gass Margery L S, Jacobs Elizabeth T, LaCroix Andrea Z, Lane Dorothy, Larson Joseph, Margolis Karen L, Millen Amy E, Sarto Gloria E, Vitolins Mara Z, Wallace Robert B   The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial Nutrition and cancer, 2011; 63(6): 827-41.
Chlebowski Rowan T, Anderson Garnet L   The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment Journal of the National Cancer Institute, 2011; 103(4): 284-5.
Chlebowski Rowan T   The obesity and breast cancer connection: advancing the agenda Oncology (Williston Park, N.Y.), 2011; 25(11): 1007, 1011-2.
Chlebowski Rowan T   Vitamin D and breast cancer: interpreting current evidence Breast cancer research : BCR, 2011; 13(4): 217.
Kabat Geoffrey C, Kim Mimi, Shikany James M, Rodgers Allison K, Wactawski-Wende Jean, Lane Dorothy, Powell Lynda, Stefanick Marcia L, Freiberg Matthew S, Kazlauskaite Rasa, Chlebowski Rowan T, Wassertheil-Smoller Sylvia, Rohan Thomas E   Alcohol consumption and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010; 19(8): 2066-72.
Li Christopher I, Chlebowski Rowan T, Freiberg Matthew, Johnson Karen C, Kuller Lewis, Lane Dorothy, Lessin Lawrence, O'Sullivan Mary Jo, Wactawski-Wende Jean, Yasmeen Shagufta, Prentice Ross   Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study Journal of the National Cancer Institute, 2010; 102(18): 1422-31.
Bertone-Johnson Elizabeth R, Chlebowski Rowan T, Manson Joann E, Wactawski-Wende Jean, Aragaki Aaron K, Tamimi Rulla M, Rexrode Kathryn M, Thomson Cynthia A, Rohan Thomas E, Peck Jennifer D, Pisano Etta D, Martin Christopher F, Sarto Gloria, McTiernan Anne   Dietary vitamin D and calcium intake and mammographic density in postmenopausal women Menopause (New York, N.Y.), 2010; 17(6): 1152-60.
Chlebowski Rowan T, Anderson Garnet, Manson JoAnn E, Pettinger Mary, Yasmeen Shagufta, Lane Dorothy, Langer Robert D, Hubbell F Allan, McTiernan Anne, Hendrix Susan, Schenken Robert, Stefanick Marcia L   Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010; 28(16): 2690-7.
Chlebowski Rowan T, Anderson Garnet L, Gass Margery, Lane Dorothy S, Aragaki Aaron K, Kuller Lewis H, Manson JoAnn E, Stefanick Marcia L, Ockene Judith, Sarto Gloria E, Johnson Karen C, Wactawski-Wende Jean, Ravdin Peter M, Schenken Robert, Hendrix Susan L, Rajkovic Aleksandar, Rohan Thomas E, Yasmeen Shagufta, Prentice Ross L, Prentice Ross L   Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women JAMA : the journal of the American Medical Association, 2010; 304(15): 1684-92.
Chlebowski Rowan T, Stefanick Marcia L   Hormone therapy suspension and mammography in Women's Health Initiative clinical trials Annals of internal medicine, 2010; 152(2): 133.
Chlebowski Rowan T   Lifestyle and breast cancer risk: the way forward? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010; 28(9): 1445-7.
Chlebowski Rowan T, Anderson Garnet L, Manson JoAnn E, Schwartz Ann G, Wakelee Heather, Gass Margery, Rodabough Rebecca J, Johnson Karen C, Wactawski-Wende Jean, Kotchen Jane Morley, Ockene Judith K, O'Sullivan Mary Jo, Hubbell F Allan, Chien Jason W, Chen Chu, Stefanick Marcia L   Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial Journal of the National Cancer Institute, 2010; 102(18): 1413-21.
Li Christopher I, Mathes Robert W, Bluhm Elizabeth C, Caan Bette, Cavanagh Mary F, Chlebowski Rowan T, Michael Yvonne, O'Sullivan Mary Jo, Stefanick Marcia L, Prentice Ross   Migraine history and breast cancer risk among postmenopausal women Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010; 28(6): 1005-10.
Chlebowski Rowan T, Chen Zhao, Cauley Jane A, Anderson Garnet, Rodabough Rebecca J, McTiernan Anne, Lane Dorothy S, Manson Joann E, Snetselaar Linda, Yasmeen Shagufta, O'Sullivan Mary Jo, Safford Monika, Hendrix Susan L, Wallace Robert B   Oral bisphosphonate use and breast cancer incidence in postmenopausal women Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010; 28(22): 3582-90.
Chlebowski Rowan T, Menon Rashmi, Chaisanguanthum Roslyn M, Jackson D Marie   Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial Clinical trials (London, England), 2010; 7(6): 744-8.
Chlebowski Rowan T   Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy Journal of the National Cancer Institute, 2010; 102(2): 137.
Kabat Geoffrey C, Kim Mimi, Wactawski-Wende Jean, Lane Dorothy, Adams-Campbell Lucile L, Gaudet Mia, Stefanick Marcia L, Vitolins Mara, Chlebowski Rowan T, Wassertheil-Smoller Sylvia, Rohan Thomas E   Recreational physical activity, anthropometric factors, and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women Cancer causes & control : CCC, 2010; 21(12): 2173-81.
Prentice Ross L, Huang Ying, Hinds David A, Peters Ulrike, Cox David R, Beilharz Erica, Chlebowski Rowan T, Rossouw Jacques E, Caan Bette, Ballinger Dennis G   Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010; 19(1): 74-9.
Kabat Geoffrey C, Kim Mimi, Chlebowski Rowan T, Khandekar Janu, Ko Marcia G, McTiernan Anne, Neuhouser Marian L, Parker Donna R, Shikany James M, Stefanick Marcia L, Thomson Cynthia A, Rohan Thomas E   A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009; 18(7): 2046-53.
Rohan Thomas E, Negassa Abdissa, Chlebowski Rowan T, Ceria-Ulep Clementina D, Cochrane Barbara B, Lane Dorothy S, Ginsberg Mindy, Wassertheil-Smoller Sylvia, Page David L   A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease Breast cancer research and treatment, 2009; 116(2): 339-50.
Zon Robin T, Goss Elizabeth, Vogel Victor G, Chlebowski Rowan T, Jatoi Ismail, Robson Mark E, Wollins Dana S, Garber Judy E, Brown Powel, Kramer Barnett S, Kramer Barnett S   American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009; 27(6): 986-93.
Visvanathan Kala, Chlebowski Rowan T, Hurley Patricia, Col Nananda F, Ropka Mary, Collyar Deborah, Morrow Monica, Runowicz Carolyn, Pritchard Kathleen I, Hagerty Karen, Arun Banu, Garber Judy, Vogel Victor G, Wade James L, Brown Powel, Cuzick Jack, Kramer Barnett S, Lippman Scott M, Lippman Scott M   American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009; 27(19): 3235-58.
Chlebowski Rowan T   Aromatase inhibitor-associated arthralgias Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009; 27(30): 4932-4.
Chlebowski Rowan T, Kuller Lewis H, Prentice Ross L, Stefanick Marcia L, Manson JoAnn E, Gass Margery, Aragaki Aaron K, Ockene Judith K, Lane Dorothy S, Sarto Gloria E, Rajkovic Aleksandar, Schenken Robert, Hendrix Susan L, Ravdin Peter M, Rohan Thomas E, Yasmeen Shagufta, Anderson Garnet, Anderson Garnet   Breast cancer after use of estrogen plus progestin in postmenopausal women The New England journal of medicine, 2009; 360(6): 573-87.
Chlebowski Rowan T   Caution regarding 25-hydroxyvitamin D monitoring in women with breast cancer Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009; 27(24): e72-3; author reply e74.
Prentice Ross L, Pettinger Mary, Beresford Shirley A A, Wactawski-Wende Jean, Hubbell F Allan, Stefanick Marcia L, Chlebowski Rowan T   Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009; 18(5): 1531-7.
McTiernan Anne, Chlebowski Rowan T, Martin Christopher, Peck Jennifer David, Aragaki Aaron, Pisano Etta D, Wang C Y, Johnson Karen C, Manson Joann E, Wallace Robert B, Vitolins Mara Z, Heiss Gerardo   Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009; 27(36): 6135-43.
Chlebowski Rowan T, Tagawa Tomoko   Early breast and prostate cancer and clinical outcomes (fracture) Oncology (Williston Park, N.Y.), 2009; 23(14 Suppl 5): 16-20.
Hoy M Katherine, Winters Barbara L, Chlebowski Rowan T, Papoutsakis Constantina, Shapiro Alice, Lubin Michele P, Thomson Cynthia A, Grosvenor Mary B, Copeland Trisha, Falk Elyse, Day Kristina, Blackburn George L   Implementing a low-fat eating plan in the Women's Intervention Nutrition Study Journal of the American Dietetic Association, 2009; 109(4): 688-96.
Michael Yvonne L, Carlson Nichole E, Chlebowski Rowan T, Aickin Mikel, Weihs Karen L, Ockene Judith K, Bowen Deborah J, Ritenbaugh Cheryl   Influence of stressors on breast cancer incidence in the Women's Health Initiative Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2009; 28(2): 137-46.
Kabat Geoffrey C, Kim Mimi, Adams-Campbell Lucile L, Caan Bette J, Chlebowski Rowan T, Neuhouser Marian L, Shikany James M, Rohan Thomas E, Rohan Thomas E   Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women The American journal of clinical nutrition, 2009; 90(1): 162-9.
Chlebowski Rowan T   Menopausal hormone therapy, hormone receptor status, and lung cancer in women Seminars in oncology, 2009; 36(6): 566-71.
Crandall Carolyn J, Aragaki Aaron K, Chlebowski Rowan T, McTiernan Anne, Anderson Garnet, Hendrix Susan L, Cochrane Barbara B, Kuller Lewis H, Cauley Jane A   New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk Archives of internal medicine, 2009; 169(18): 1684-91.
Chlebowski Rowan T, Schwartz Ann G, Wakelee Heather, Anderson Garnet L, Stefanick Marcia L, Manson JoAnn E, Rodabough Rebecca J, Chien Jason W, Wactawski-Wende Jean, Gass Margery, Kotchen Jane Morley, Johnson Karen C, O'Sullivan Mary Jo, Ockene Judith K, Chen Chu, Hubbell F Allan, Hubbell F Allan   Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial Lancet, 2009; 374(9697): 1243-51.
Kabat Geoffrey C, Kim Mimi, Caan Bette J, Chlebowski Rowan T, Gunter Marc J, Ho Gloria Y F, Rodriguez Beatriz L, Shikany James M, Strickler Howard D, Vitolins Mara Z, Rohan Thomas E   Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer International journal of cancer. Journal international du cancer, 2009; 125(11): 2704-10.
Kwan Karen W, Chlebowski Rowan T   Sexual dysfunction and aromatase inhibitor use in survivors of breast cancer Clinical breast cancer, 2009; 9(4): 219-24.
Prentice Ross L, Huang Ying, Hinds David A, Peters Ulrike, Pettinger Mary, Cox David R, Beilharz Erica, Chlebowski Rowan T, Rossouw Jacques E, Caan Bette, Ballinger Dennis G   Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009; 18(11): 3079-85.
Kabat Geoffrey C, Kim Mimi, Hunt Julie R, Chlebowski Rowan T, Rohan Thomas E   Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative American journal of epidemiology, 2008; 168(2): 158-69.
Chlebowski Rowan T, Johnson Karen C, Kooperberg Charles, Pettinger Mary, Wactawski-Wende Jean, Rohan Tom, Rossouw Jacques, Lane Dorothy, O'Sullivan Mary Jo, Yasmeen Shagufta, Hiatt Robert A, Shikany James M, Vitolins Mara, Khandekar Janu, Hubbell F Allan, Hubbell F Allan   Calcium plus vitamin D supplementation and the risk of breast cancer Journal of the National Cancer Institute, 2008; 100(22): 1581-91.
Chlebowski Rowan T   Clinical trial presentations, agency guidelines, and oncology practice: findings from the arimidex, tamoxifen, alone or in combination trial Clinical breast cancer, 2008; 8(4): 343-6.
Rohan Thomas E, Negassa Abdissa, Chlebowski Rowan T, Habel Laurel, McTiernan Anne, Ginsberg Mindy, Wassertheil-Smoller Sylvia, Page David L   Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial Journal of the National Cancer Institute, 2008; 100(8): 563-71.
Prentice Ross L, Chlebowski Rowan T, Stefanick Marcia L, Manson Joann E, Langer Robert D, Pettinger Mary, Hendrix Susan L, Hubbell F Allan, Kooperberg Charles, Kuller Lewis H, Lane Dorothy S, McTiernan Anne, O'Sullivan Mary Jo, Rossouw Jacques E, Anderson Garnet L   Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study American journal of epidemiology, 2008; 167(12): 1407-15.
Ritenbaugh Cheryl, Stanford Janet L, Wu LieLing, Shikany James M, Schoen Robert E, Stefanick Marcia L, Taylor Vicky, Garland Cedric, Frank Gail, Lane Dorothy, Mason Ellen, McNeeley S Gene, Ascensao Joao, Chlebowski Rowan T, Chlebowski Rowan T   Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008; 17(10): 2609-18.
Rohan Thomas E, Negassa Abdissa, Chlebowski Rowan T, Lasser Norman L, McTiernan Anne, Schenken Robert S, Ginsberg Mindy, Wassertheil-Smoller Sylvia, Page David L   Estrogen plus progestin and risk of benign proliferative breast disease Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008; 17(9): 2337-43.
Prentice Ross L, Chlebowski Rowan T, Stefanick Marcia L, Manson Joann E, Pettinger Mary, Hendrix Susan L, Hubbell F Allan, Kooperberg Charles, Kuller Lewis H, Lane Dorothy S, McTiernan Anne, Jo O'Sullivan Mary, Rossouw Jacques E, Anderson Garnet L   Estrogen plus progestin therapy and breast cancer in recently postmenopausal women American journal of epidemiology, 2008; 167(10): 1207-16.
Rohan Thomas E, Negassa Abdissa, Caan Bette, Chlebowski Rowan T, Curb J David, Ginsberg Mindy, Lane Dorothy S, Neuhouser Marian L, Shikany James M, Wassertheil-Smoller Sylvia, Page David L   Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial Cancer prevention research (Philadelphia, Pa.), 2008; 1(4): 275-84.
Chlebowski Rowan T, Prentice Ross L   Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution Journal of the National Cancer Institute, 2008; 100(19): 1341-3.
Chlebowski Rowan T   Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer Breast cancer research and treatment, 2008; 112 Suppl 1(6): 25-34.
Chlebowski Rowan T, Col Nananda   Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis Journal of the National Cancer Institute, 2008; 100(18): 1331-2; author reply 132-3.
Col Nananda F, Chlebowski Rowan T   Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk Menopause (New York, N.Y.), 2008; 15(4 Suppl): 804-9.
Chlebowski Rowan T, Prentice Ross   Tibolone in older postmenopausal women The New England journal of medicine, 2008; 359(20): 2172-3; author reply 2173.
Chlebowski Rowan T   Toward optimal health: advances in breast cancer detection and management. Interview by Jodi R. Godfrey Journal of women's health (2002), 2008; 17(7): 1067-70.
Chlebowski Rowan T   Translating trial data into patients benefits: making the right choice Breast (Edinburgh, Scotland), 2008; 17 Suppl 3(8): S9-15.
Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR   American society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004 J Clin Oncol, 2005; 23(3): 619-29.
Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E   Estrogen plus progestin and colorectal cancer in postmenopausal women The New England journal of medicine. , 2004; 350(10): 991-1004.
Chlebowski RT, Pettinger M, Stefanick ML, Howard BV, Mossavar-Rahmani Y, McTiernan A   Insulin, physical activity, and caloric intake in postmenopausal women: breast cancer implications Journal of clinical oncology : official journal of the American Society of Clinical Oncology. , 2004; 22(22): 4507-13.
Chlebowski RT, Col N   Menopausal hormone therapy after breast cancer Lancet, 2004; 363(9407): 410-1.
Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, Cauley JA, Blumenstein BA, Albain KS, Lipton A, Brown S   American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer J Clin Oncol, 2003; 21(21): 4042-57.
Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP   American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting J Clin Oncol, 2003; 21(13): 2597-9.
Chlebowski RT, McTiernan A   Biological significance of interventions that change breast density Journal of the National Cancer Institute. , 2003; 95(1): 4-5.
Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A   Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative Cancer research. , 2003; 63(18): 6096-101.
Chlebowski RT, Kim JA, Col NF   Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapy Seminars in oncology. , 2003; 30(6): 776-88.
Yasmeen S, Romano PS, Pettinger M, Chlebowski RT, Robbins JA, Lane DS, Hendrix SL   Frequency and predictive value of a mammographic recommendation for short-interval follow-up Journal of the National Cancer Institute. , 2003; 95(6): 429-36.
Geller ML, Chlebowski RT   HT and breast cancer risk Fertil Steril, 2003; 80 Suppl 4: 5-9.
Yasmeen S, Romano PS, Pettinger M, Chlebowski RT, Robbins JA, Lane DS, Hendrix SL   Re: Short-interval follow-up mammography: are we doing the right thing? Journal of the National Cancer Institute. , 2003; 95(15): 1175-6.
Chlebowski RT   The American Cancer Society guide for nutrition and physical activity for cancer survivors: a call to action for clinical investigators CA: a cancer journal for clinicians. , 2003; 53(5): 266-7.

Does this profile need updating? Contact Us